Robertet S.A. (0NZN)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 779.69 |
|---|---|
| 52-week range | 716.00 – 915.00 |
| Return, 1 month / 3 months | +3.6% / −2.0% |
| Return, 1 year / 3 years | −5.0% / +4.3% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Robertet S.A. is a French company based in Grasse that produces natural raw materials for the fragrance, flavour and cosmetics industries. It makes essential oils, absolutes, extracts and other botanical ingredients derived from flowers, fruits, woods and resins, and also creates fragrance and flavour compositions. Its customers are perfume houses, flavour manufacturers, food and beverage producers and cosmetics companies, served across international markets. The business is family controlled and has long-standing ties to the perfumery trade of southern France.
Robertet S.A. trades under the code 0NZN on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Robertet S.A. (0NZN) trades on the London Exchange in UK. It last closed at EUR 779.69 on 23 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,353 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.0% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.8% | ||
| From 52-week high | -14.8% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | -2.8% | ||
| 12-month return, skipping the last month | -8.3% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 20.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +3.6% |
| 3 months | −2.0% |
| 6 months | −2.8% |
| 1 year | −5.0% |
| 3 years | +4.3% |
| 5 years | −13.2% |
Signals
| 50-day / 200-day average | 772.61 / 810.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Jun 2026 | EUR 12.0000 |
| 27 Jun 2025 | EUR 10.0000 |
| 27 Jun 2024 | EUR 8.5000 |
| 29 Jun 2023 | EUR 8.5000 |
| 29 Jun 2022 | EUR 8.0000 |
| 29 Jun 2021 | EUR 5.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.